Does CAS Make Sense?
Client Alert | 1 min read | 06.22.20
Partner Nicole Owren-Wiest appeared on an episode of Baker Tilly’s Fed Talks podcast to discuss Cost Accounting Standards. The episode addresses questions about the background and theory behind CAS, whether CAS successfully establishes the original mission of the CAS Board, and what contractors can do to ensure success when they make cost accounting practice changes.
Click below to listen via the embedded player or access from one of these links:
Baker Tilly | Apple Podcasts | Google Podcasts
Contacts
Partner
She/Her/Hers
Insights
Client Alert | 4 min read | 04.18.24
Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2]
Client Alert | 6 min read | 04.16.24
Navigating the AI Intellectual Property Maze - Key Points From Congressional Hearing
Client Alert | 5 min read | 04.15.24
Making the EU Courts More Efficient for Trade-Related Decisions
Client Alert | 1 min read | 04.15.24
New FAR Part 40 to Address Supply Chain and Information Security Requirements
